Open access
Open access
Powered by Google Translator Translator

All Posts

The WHO estimates of excess mortality associated with the COVID-19 pandemic

9 Jan, 2023 | 14:48h | UTC

The WHO estimates of excess mortality associated with the COVID-19 pandemic – Nature

Commentary: Pandemic’s Two-Year Global Death Toll May Be Close to 15 Million – HealthDay

 


Scientists tie third clinical trial death to experimental Alzheimer’s drug

9 Jan, 2023 | 14:47h | UTC

Scientists tie third clinical trial death to experimental Alzheimer’s drug – Science

Related: RCT | Lecanemab slows cognitive decline in early Alzheimer’s disease but raises safety concerns.

 


ESC/AHA/ACC/WHF Joint Opinion | Randomized trials fit for the 21st century

9 Jan, 2023 | 14:44h | UTC

Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation – Circulation

Commentaries:

It’s Time to Revamp How Clinical Trials Are Done, Say Cardiology Societies – TCTMD

World Cardiology Societies Call for Reinvention of Randomized Clinical Trials – Cardiac Interventions Today

 

Commentary on Twitter

 


Consensus Guideline | Management of the perioperative patient on cannabis and cannabinoids

9 Jan, 2023 | 14:43h | UTC

ASRA pain medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids – Regional Anesthesia & Pain Medicine

News Release: All Patients Should be Screened for Cannabis Use Before Surgery, First U.S. Guidelines Recommend – American Society of Regional Anesthesia and Pain Medicine

 

Commentary on Twitter

https://twitter.com/ASRA_Society/status/1610269709374554114

 


ASCO Guideline | Immunotherapy and targeted therapy for advanced gastroesophageal cancer

9 Jan, 2023 | 14:40h | UTC

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline – Journal of Clinical Oncology

News Release: First ASCO Guideline for Immunotherapy and Targeted Therapy in Advanced Gastroesophageal Cancer Now Available – ASCO Daily News

 


ASCO Guideline | Immunotherapy and biomarker testing in recurrent and metastatic head and neck cancers

9 Jan, 2023 | 14:41h | UTC

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline – Journal of Clinical Oncology

News Release: ASCO Publishes New Guideline on Immunotherapy, Biomarker Testing in Advanced Head and Neck Cancer – ASCO Daily News

 


Cohort Study | Association of habitual checking behaviors on social media with longitudinal functional brain development

9 Jan, 2023 | 14:38h | UTC

Association of Habitual Checking Behaviors on Social Media With Longitudinal Functional Brain Development – JAMA Pediatrics (link to abstract – $ for full-text)

Commentaries:

Social Media Checking Behaviors in Teens Linked to Brain Changes – HealthDay

For adolescents, social media might be a brain-changer, researchers say – CNN

 


M-A | Physical activity interventions to alleviate depressive symptoms in children and adolescents

9 Jan, 2023 | 14:37h | UTC

Physical Activity Interventions to Alleviate Depressive Symptoms in Children and Adolescents: A Systematic Review and Meta-analysis – JAMA Pediatrics (link to abstract – $ for full-text)

Commentary: Exercise, Sports: A Natural Antidepressant for Teens – HealthDay

 

Commentary on Twitter

 


The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischemic heart disease

9 Jan, 2023 | 14:28h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischaemic heart disease – European Heart Journal

 

Commentary on Twitter

 


The year in cardiovascular medicine 2022: the top 10 papers in dyslipidemias

9 Jan, 2023 | 14:26h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias – European Heart Journal

 

Commentary on Twitter

 


The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies

9 Jan, 2023 | 14:10h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies – European Heart Journal

 

Commentary on Twitter

 


The year in cardiovascular medicine 2022: the top 10 papers in cardiovascular imaging

9 Jan, 2023 | 14:21h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in cardiovascular imaging – European Heart Journal

 

Commentary on Twitter

 


The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias

9 Jan, 2023 | 14:19h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias – European Heart Journal

 

Commentary on Twitter

 


The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology

9 Jan, 2023 | 14:08h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology – European Heart Journal

 

Commentary on Twitter

 


Phase 1-2 study | Adagrasib with or without Cetuximab in colorectal cancer with mutated KRAS G12C

9 Jan, 2023 | 14:04h | UTC

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Advanced Colorectal Cancer Treatment Targets KRAS Gene With Drug Combo – Memorial Sloan Kettering Cancer Center

 

Commentary on Twitter

 


Left heart catheterization complications | ED presentations, evaluation, and management

9 Jan, 2023 | 14:07h | UTC

Left Heart Catheterization Complications: ED Presentations, Evaluation, and Management – emDocs

 


Review | Transmission of Group B Streptococcus in late-onset neonatal disease

9 Jan, 2023 | 14:05h | UTC

Transmission of Group B Streptococcus in late-onset neonatal disease: a narrative review of current evidence – Therapeutic Advances in Infectious Disease

 


M-A | Laparoscopic vs. open pancreatoduodenectomy in patients with periampullary tumors

9 Jan, 2023 | 14:02h | UTC

Laparoscopic versus Open Pancreatoduodenectomy in Patients with Periampullary Tumors: A Systematic Review and Meta-analysis – Annals of Surgery (link to abstract – $ for full-text)

Related: Comparison of safety and effectiveness between laparoscopic and open pancreatoduodenectomy: A systematic review and meta-analysis – International Journal of Surgery

 


M-A | Safety outcomes of direct discharge home from ICUs

9 Jan, 2023 | 14:01h | UTC

Safety Outcomes of Direct Discharge Home From ICUs: An Updated Systematic Review and Meta-Analysis (Direct From ICU Sent Home Study)* – Critical Care Medicine

 

Commentary from the author on Twitter (thread – click for more)

 


RCT | Nonoperative vs. operative treatment for displaced finger metacarpal shaft fractures

9 Jan, 2023 | 13:58h | UTC

Nonoperative Versus Operative Treatment for Displaced Finger Metacarpal Shaft Fractures: A Prospective, Noninferiority, Randomized Controlled Trial – The Journal of Bone and Joint Surgery

 


M-A | Prediction of difficult laryngoscopy using ultrasound

9 Jan, 2023 | 13:59h | UTC

Prediction of Difficult Laryngoscopy Using Ultrasound: A Systematic Review and Meta-Analysis – Critical Care Medicine (link to abstract – $ for full-text)

 


Happy Holidays! We will return with our activities on January 9, 2023. Any breakthrough articles during this break will be delivered at the beginning of the year.

19 Dec, 2022 | 03:46h | UTC


Review | Voice restoration in mechanically ventilated intensive care unit patients with a tracheostomy

9 Jan, 2023 | 13:44h | UTC

Benefits and options for voice restoration in mechanically ventilated intensive care unit patients with a tracheostomy – Journal of the Intensive Care Society

 


WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets.

16 Dec, 2022 | 13:52h | UTC

WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets – World Health Organization

News Release: WHO calls on countries to tax sugar-sweetened beverages to save lives – World Health Organization

Related:

M-A: Outcomes following taxation of sugar-sweetened beverages.

Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents – Pediatrics

Cutting back on sugar-sweetened beverages: What works? – Cochrane Library

Association of a Beverage Tax on Sugar-Sweetened and Artificially Sweetened Beverages With Changes in Beverage Prices and Sales at Chain Retailers in a Large Urban Setting – JAMA

Impact of sugar‐sweetened beverage taxes on purchases and dietary intake: Systematic review and meta‐analysis – Obesity Reviews

Association between tax on sugar sweetened beverages and soft drink consumption in adults in Mexico: open cohort longitudinal analysis of Health Workers Cohort Study – The BMJ

Potential impact on prevalence of obesity in the UK of a 20% price increase in high sugar snacks: modelling study – The BMJ

Changes in food purchases after the Chilean policies on food labelling, marketing, and sales in schools: a before and after study – The Lancet Planetary Health

Association of a Sweetened Beverage Tax With Soda Consumption in High School Students – JAMA Pediatrics

Sugar-sweetened beverage taxes: Lessons to date and the future of taxation – PLOS Medicine

Banning the promotion of soft drinks could be more effective than a sugar tax – The Conversation

Sugar tax: why health experts want it but politicians and industry are resisting – The Guardian

 

Commentary on Twitter

 


RCT | Chlorthalidone (12.5-25 mg) and Hydrochlorothiazide (25-50 mg) are similarly effective for the prevention of CVD in hypertensive patients.

16 Dec, 2022 | 13:49h | UTC

Chlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: ‘Burden-free’ study method finds two blood pressure drugs equally effective – Veterans Affairs Research Communications

Related (news release and commentaries before publication): RCT | Chlortalidone and Hydrochlorothiazide resulted in similar reductions of CVD in older patients with hypertension.

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.